Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$93.5M Sell
3,734,142
-204,499
-5% -$4.84M 2.98% 9
2025
Q4
$104M Hold
3,938,641
3.49% 9
2025
Q3
$67.3M Sell
3,938,641
-370,294
-9% -$5.3M 2.73% 14
2025
Q2
$54.1M Hold
4,308,935
1.93% 10
2025
Q1
$51.3M Hold
4,308,935
2.09% 10
2024
Q4
$63.1M Sell
4,308,935
-299,000
-6% -$4.18M 2.14% 10
2024
Q3
$57.8M Sell
4,607,935
-1,262,065
-22% -$13.7M 1.69% 18
2024
Q2
$50M Hold
5,870,000
1.4% 23
2024
Q1
$61.8M Hold
5,870,000
1.7% 16
2023
Q4
$61M Hold
5,870,000
1.53% 18
2023
Q3
$37.2M Hold
5,870,000
1% 24
2023
Q2
$50.7M Hold
5,870,000
1.41% 19
2023
Q1
$53.1M Hold
5,870,000
1.94% 16
2022
Q4
$46.1M Buy
+5,870,000
New +$41.2M 1.95% 18
2018
Q4
Sell
-19,804
Closed -$311K 56
2018
Q3
$311K Hold
19,804
0.03% 57
2018
Q2
$293K Buy
+19,804
New +$307K 0.03% 51

Other funds holding ZYME

BVF Inc's ZYME Position: Q1 2026 in Review

BVF Inc reduced its Zymeworks (ZYME) stake by 5.2% in Q1 2026, selling an estimated $4.84M and leaving 3,734,142 shares worth $93.5M. The position accounts for 2.98% of the portfolio, ranked #9.

BVF Inc first reported a position in ZYME in Q2 2018 and has held it in 16 quarters since. The position peaked at $104M in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • BVF Inc held 3,734,142 shares of Zymeworks worth $93.5M as of Q1 2026.
  • BVF Inc sold 204,499 Zymeworks shares in Q1 2026, an estimated $4.84M.
  • Zymeworks made up 2.98% of BVF Inc's portfolio in Q1 2026, its #9 holding.
  • BVF Inc first reported a position in Zymeworks in Q2 2018 and has held it in 16 quarters since.
  • BVF Inc's Zymeworks position peaked at $104M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on BVF Inc's 13F filing for Q1 2026, filed 15 May 2026.